Pulsatile systems for colon targeting of budesonide: In vitro and in vivo evaluation

References

• Baker, D.E. (2001). Budesonide modified release capsules. Rev Gastroenterol Disord. 1:147–55.
   PubMedGoogle Scholar
• Cui, N., Friend, D.R., Fedorak, R.N. (1994). A budesonide prodrug accelerates treatment of colitis in rats. Gut. 3510:1439–46.
   Google Scholar
• Depoortere, I., Van Assche, G., Thijs, T., Geboes, K., Peeters, T.L. (1999). Differential changes in ACh-, motilin-, substance P-, and K(+)-induced contractility in rabbit colitis. Am J Physiol. 277:61–8.
   Google Scholar
• Edsbäcker, S., Bengtsson, B., Larsson, P., Lundin, P., Nilsson, A., Ulmius, J., Wollmer, P. (2003). A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules. Aliment Pharmacol Ther. 15:525–36.
   Google Scholar
• Feagan, B.G., Sandborn, W.J. (2002). Initial therapy for mild to moderate Crohn’s disease: Mesalmaine or budesonide? Rev Gastroenterol Disord. 2:s9–s15.
   PubMedGoogle Scholar
• Gliko-Kabir, I., Yagen, B., Baluom, M., Rubinstein, A. (2000). Phosphated crosslinked guar for colon-specific drug delivery. II. In vitro and in vivo evaluation in the rat. J Contr Rel. 63:129–34.
   PubMed Web of Science ®Google Scholar
• Hinton, J.M., Lennard-Jonnes, J.E., Young, A.C. (1969). A new method for studying gut transit times using radioopaque markers. Gut. 10:842.
   PubMed Web of Science ®Google Scholar
• Ibekwe, V.C., Fadda, H.M., Parsons, G.E., Basit, A.W. (2006a). A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. Int J Pharm. 308:52–60.
   PubMed Web of Science ®Google Scholar
• Ibekwe, V.C., Liu, F., Fadda, H., Khela, M.K., Evans, D.F., Parsons, G.E., Basit, A.W. (2006b). An Investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. J Pharm Sci. 95:2760–6.
   PubMed Web of Science ®Google Scholar
• Jeong, Y.I., Ohno, T., Hu, Z., Yoshikawa, Y., Shibata, N., Nagata, S., Takada, K. (2001). Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method. J Contr Rel. 71:175–82.
   PubMed Web of Science ®Google Scholar
• Kakoulides, E.P., Smart, J.D., Tsibouklis, J. (1998). Azocrosslinked poly (acrylic acid) for colonic delivery and adhesion specificity: Synthesis and characterization. J Contr Rel. 52:291–300.
   PubMed Web of Science ®Google Scholar
• Kaus, L.C., Fell, J.T., Sharma, H., Taylor, D.C. (1984). The intestinal transit of a single non-disintegrating object. Int J Pharm. 14:143–8.
   Google Scholar
• Klotz, U., Schwab, M. (2005). Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Deliv Rev. 57:267–79.
   PubMed Web of Science ®Google Scholar
• Krishnaiah, Y.S., Satyanarayana, V., Dinesh Kumar, B., Karthikeyan, R.S. (2002). In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci. 16:185–92.
   PubMed Web of Science ®Google Scholar
• Krishnamachari, Y., Madan, P., Lin, S. (2007). Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Int J Pharm. 338:238–47.
   PubMed Web of Science ®Google Scholar
• Mastiholimath, V.S., Dandagi, P.M., Jain, S.S., Gadad, A.P., Kulkarni, A.R. (2007). Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Int J Pharm. 328:49–56.
   PubMed Web of Science ®Google Scholar
• McConville, J.T., Ross, A.C., Chambers, A.R., Smith, G., Florence, A.J., Stevens, H.N.E. (2004). The effect of wet granulation on the erosion behaviour of an HPMC–lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation. Eur J Pharm Biopharm. 57:541–9.
   PubMed Web of Science ®Google Scholar
• Ritger, P.L., Peppas, N.A. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Contr Rel. 5:37–42.
   Google Scholar
• Rodriguez, M., Antunez, J.A., Taboada, C., Seijo, B., Torres, D. (2001). Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. J Pharm Pharmacol. 53:1207–1215.
   PubMed Web of Science ®Google Scholar
• Rodriguez, M., Vila-Jato, J.L., Torres, D. (1998). Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Contr Rel. 55:67–77.
   PubMed Web of Science ®Google Scholar
• Rönnblom, A., Samuelsson, S.M., Ekbom, A. (2010). Ulcerative colitis in the county of Uppsala 1945–2007: Incidence and clinical characteristics. J Crohns Colitis. 4:532–6.
   PubMed Web of Science ®Google Scholar
• Sawada, T., Sako, K., Fukui, M., Yokohamaa, S., Hayashi, M. (2003). A new index, the core erosion ratio, of compression-coated timed-release tablets predicts the bioavailability of acetaminophen. Int J Pharm. 265:55–63.
   PubMed Web of Science ®Google Scholar
• Schellekens, R.C.A., Stellaard, F., Olsder, G.G., Woerdenbag, H.J., Frijlink, H.W., Kosterink, J.G.W. (2010). Oral ileocolonic drug delivery by the colopulse-system: A bioavailability study in healthy volunteers. J Contr Rel. 146:334–40.
   PubMed Web of Science ®Google Scholar
• Shin, D.H., Sinn, D.H., Kim, Y.H., Kim, J.Y., Chang, D.K., Kim, E.J., Ryu, H.Y., Song, H.U., Kim, I.Y., Kim do, H., Kim, Y.Y., Kim, S.H., Seo, Y.B., Hwang, K.W., Kim, J.J. (2011). Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008. Dig Dis Sci. 56:1154–9.
   PubMed Web of Science ®Google Scholar
• Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A., Muranishi, S. (1997). Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon. J Pharm Sci. 86:1016–21.
   PubMed Web of Science ®Google Scholar
• Turkoglu, M., Ugurlu, T. (2002). In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm. 53:65–73.
   PubMed Web of Science ®Google Scholar
• Wilding, I.R., Davis, S.S., Bakhshaee, M., Stevens, H.N., Sparrow, R.A., Brennan, J. (1992). Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. Pharm Res. 9:654–7.
   PubMed Web of Science ®Google Scholar
• Wilson, J., Hair, C., Knight, R., Catto-Smith, A., Bell, S., Kamm, M., Desmond, P., McNeil, J., Connell, W. (2010). High incidence of inflammatory bowel disease in Australia: A prospective population-based Australian incidence study. Inflamm Bowel Dis. 16:1550–6.
   PubMed Web of Science ®Google Scholar
• Wong, D., Larrabee, S., Clifford, K., Tremblay, J., Friend, D. (1997). USP dissolution apparatus III (reciprocating cylinder) for screening of guar-based colonic delivery formulations. J Contr Rel. 47:173–9.
   Web of Science ®Google Scholar
• Yehia, S.A., Elshafeey, A.H., Sayed, I., Shehata, A.H. (2009). Optimization of budesonoide compression-coated tablets for colonic delivery. AAPS PharmSciTec. 10:147–57.
   PubMed Web of Science ®Google Scholar
• Yu, D.K., Morrill, B., Eichmeier, L.S. (1995). Pharmacokinetics of 5-aminosalicylic acid in man. Eur J Clin Pharmacol. 48:273–7.
   PubMed Web of Science ®Google Scholar
• Zheng, J.J., Zhu, X.S., Huangfu, Z., Shi, X.H., Guo, Z.R. (2010). Prevalence and incidence rates of Crohn’s disease in mainland China: A meta-analysis of 55 years of research. J Dig Dis. 11:161–6.
   PubMed Web of Science ®Google Scholar